When NNMT is active, fat cells become metabolically lazy. By blocking it, this peptide reactivates fat cell metabolism, increases NAD+ availability in adipose tissue, and essentially flips a switch from fat-storing to fat-burning at the cellular level
Guided by our experienced medical team, each program is designed around your specific needs for sustainable, long-term results
This article is exclusive to STAT+ subscribers Unlock this article plus daily intelligence on Capitol Hill and the life sciences industry by subscribing to STAT+
Frequently asked questions What is the standard BPC-157 dosage
Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use
Manufactured under cGMP (current Good Manufacturing Practice) conditions and meeting United States Pharmacopoeia (USP) monograph standards, this product carries FDA approval and is classified as prescription-only for licensed healthcare professionals
